UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation Journal article
Xie, Daping, Han, Congwei, Chen, Chonghao, Liao, Zhencheng, Campos de Souza, Senio, Niu, Yiming, Mano, João F., Dong, Lei, Wang, Chunming. A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation[J]. Bioactive Materials, 2024, 37, 315-330.
Authors:  Xie, Daping;  Han, Congwei;  Chen, Chonghao;  Liao, Zhencheng;  Campos de Souza, Senio; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:18.0/18.2 | Submit date:2024/05/16
Scaffold Vaccine  Tlr2 Agonist  Polysaccharide  Reactive Oxygen Species  Cross-presentation  
Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides Journal article
Zhu, Shiyan, Liu, Kefang, Chai, Yan, Wu, Yanan, Lu, Dan, Xiao, Wenling, Cheng, Hao, Zhao, Yingze, Ding, Chunming, Lyu, Jianxin, Lou, Yongliang, Gao, George F., Liu, William J.. Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides[J]. Frontiers in immunology, 2019, 10.
Authors:  Zhu, Shiyan;  Liu, Kefang;  Chai, Yan;  Wu, Yanan;  Lu, Dan; et al.
Favorite | TC[WOS]:12 TC[Scopus]:32  IF:5.7/6.8 | Submit date:2022/05/23
Cross-presentation  Hla Superfamily  Hla-a3  Human Immunodeficiency Virus (Hiv)  Influenza Virus  Major Histocompatibility Complex (Mhc)  Mycobacterium Tuberculosis  T-cell